tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Agilent Appoints Adam S. Elinoff as CFO

Story Highlights
  • Agilent Technologies appoints Adam S. Elinoff as CFO, effective November 17, 2025.
  • Elinoff’s experience in finance and strategy is expected to enhance Agilent’s operations and strategic planning.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Agilent Appoints Adam S. Elinoff as CFO

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Agilent ( (A) ) has shared an announcement.

On October 23, 2025, Agilent Technologies announced the appointment of Adam S. Elinoff as the new Chief Financial Officer, effective November 17, 2025. Elinoff, who previously held significant finance roles at Amgen, brings extensive experience in corporate finance, strategy, and transformation. His appointment is expected to bolster Agilent’s financial operations and strategic planning as the company aims to accelerate its Ignite Operating System and enhance value creation for customers and shareholders.

The most recent analyst rating on (A) stock is a Hold with a $130.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.

Spark’s Take on A Stock

According to Spark, TipRanks’ AI Analyst, A is a Outperform.

Agilent’s overall stock score is driven by strong financial performance and positive earnings call outcomes, highlighting robust growth and strategic initiatives. Technical indicators support a bullish trend, though valuation concerns due to a high P/E ratio and low dividend yield slightly temper the outlook.

To see Spark’s full report on A stock, click here.

More about Agilent

Agilent Technologies Inc. is a global leader in analytical and clinical laboratory technologies, providing instruments, software, services, and expertise to deliver insights and innovation in life sciences, diagnostics, and applied markets. The company reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.

Average Trading Volume: 1,638,648

Technical Sentiment Signal: Strong Buy

Current Market Cap: $41.97B

See more data about A stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1